#VisualAbstract: Induction chemotherapy does not improve survival for patients receiving chemoradiotherapy for esophageal squamous cell carcinoma
Click to read the study in Nature Communications.
Tag: esophageal squamous cell carcinoma
#VisualAbstract: Pembrolizumab plus cetuximab shows early clinical efficacy for patients with recurrent or metastatic head and neck squamous cell carcinoma
Click to read the study in The Lancet Oncology.
#VisualAbstract: Chemoradiotherapy plus surgery improves 10-year overall survival compared to surgery alone in esophageal cancer
Click to read the study in the Journal of Clinical Oncology.
Neoadjuvant chemoradiotherapy plus surgery increases overall survival of patients with advanced esophageal squamous cell carcinoma compared to surgery alone
1. Neoadjuvant chemoradiotherapy (NCRT) with surgery improves the death rate, overall survival, disease-free survival time, and locoregional and distal recurrence ...
#VisualAbstract: Docetaxel, cisplatin, and cetuximab regimen is a safe alternative for patients with squamous cell carcinoma of the head and neck
Click to read the study in The Lancet Oncology.
#VisualAbstract: Avelumab does not improve outcomes in patients receiving chemoradiotherapy for squamous cell carcinomas of the head and neck
Click to read the study in The Lancet Oncology.
#VisualAbstract: No differences in survival in patients with esophageal cancer treated with neoadjuvant chemotherapy or chemoradiotherapy followed by esophagectomy
Click to read the study in JAMA Surgery.
#VisualAbstract: Major postoperative complications are associated with worse long-term survival in patients undergoing esophagectomy
Click to read the study in JAMA Surgery.
Endoscopic screening for esophageal cancer may reduce long-term mortality
1. In a prospective cohort trial of over 3000 volunteers who live in areas with high incidence of esophageal cancer, ...